Twin Securities »

Arcellx shares owned by Twin Securities

Quarter-by-quarter ownership of Arcellx (ACLX) shares owned by Twin Securities from 13F filings

Historical chart of Twin Securities investment in Arcellx

Tip: Access up to 7 years of quarterly data

All positions including Arcellx held by Twin Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcellx by Twin Securities

Quarter filed Position value Share count Share price at filing
2026-03-31 $6.2M 54k 114.82

More positions owned by Twin Securities

Electronic Arts (EA)
Warner Bros Discovery Com Ser A (WBD)
Clearwater Analytics Hldgs I Cl A (CWAN)
Hologic
Kenvue (KVUE)
Revolution Medicines (RVMD)
Arcellx Common Stock (ACLX)
Terns Pharmaceuticals (TERN)
Apellis Pharmaceuticals (APLS)
Onestream Cl A
Take-Two Interactive Software (TTWO)
Day One Biopharmaceuticals I (DAWN)
Atrium Therapeutics (RNA)
Acuren Corporation (TIC)
Manchester Utd Ord Cl A (MANU)

View all positions for Twin Securities

Top funds holding Arcellx

T. Rowe Price Investment Management
Gilead Sciences
Paradigm Biocapital Advisors
Vanguard Group
BlackRock
FMR
NEA Management Company
Pentwater Capital Management
Vanguard Capital Management
Vanguard Portfolio Management
Sr One Capital Management
HBK Investments
State Street Corporation
Glazer Capital
Goldman Sachs Group

View all funds holding Arcellx